IGF1 and Huntington disease: According with the literature, HD patients present higher basal plasma levels of IGF-1, which have been linked to the cognitive decline seen in these patients, leading to the hypothesis that IGF-1 resistance may be one of the underlying mechanisms involved in this pathology (Saleh et al., 2010; Salem et al., 2016).